ADCETRIS 50 mg/10.5mL
brentuximab vedotin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SEAGEN INC.
ADCETRIS is a injection, powder, lyophilized, for solution containing brentuximab vedotin at 50 mg/10.5mL, taken intravenous. Manufactured by SEAGEN INC..
Key Facts
- Brand Name
- ADCETRIS
- Generic Name
- brentuximab vedotin
- NDC Code (Product)
51144-050- Manufacturer
- SEAGEN INC.
- Strength
- 50 mg/10.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125388
- Drug Class
- CD30-directed Immunoconjugate [EPC]
- Marketing Start
- 08/25/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is ADCETRIS used for?
ADCETRIS contains brentuximab vedotin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is ADCETRIS a controlled substance?
ADCETRIS is not classified as a controlled substance by the DEA.
What is the generic name for ADCETRIS?
The generic name for ADCETRIS is brentuximab vedotin. There are no other listed brand versions of brentuximab vedotin.
What is the NDC code for ADCETRIS 50 mg/10.5mL?
The NDC (National Drug Code) for ADCETRIS 50 mg/10.5mL is 51144-050, listed by SEAGEN INC..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)